By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Prometheus Laboratories and Medco Research Institute today announced a deal to evaluate Prometheus' test for identifying patients who may benefit from a therapy for inflammatory bowel disease.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.
Cancer clinical trial patients settle with Anil Potti and Duke University.
A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.
Two Johns Hopkins researchers discuss the need for evidence-based data analysis.